Welcome to LookChem.com Sign In|Join Free
  • or
3-ethyl 5-methyl 4-([1,1'-biphenyl]-3-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1099640-02-4

Post Buying Request

1099640-02-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1099640-02-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1099640-02-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,9,6,4 and 0 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1099640-02:
(9*1)+(8*0)+(7*9)+(6*9)+(5*6)+(4*4)+(3*0)+(2*0)+(1*2)=174
174 % 10 = 4
So 1099640-02-4 is a valid CAS Registry Number.

1099640-02-4Downstream Products

1099640-02-4Relevant academic research and scientific papers

Sterically hindered N-heterocyclic carbene/palladium(ii) catalyzed Suzuki-Miyaura coupling of nitrobenzenes

Chen, Kai,Chen, Wei,Yi, Xiaofei,Chen, Wanzhi,Liu, Miaochang,Wu, Huayue

, p. 9287 - 9290 (2019)

Palladium-catalyzed denitrative Suzuki coupling of nitroarenes using 2-aryl-5-(2,4,6-triisopropylphenyl)-2,3-imidazolylidene[1,5-a]pyridines as the ligands is described. The key to success is the use of the NHC ligands which show strong donating ability and suitable steric hindrance allowing the successful oxidative addition of Ar-NO2 bonds. Both aromatic and aliphatic boronic acids are tolerated, and a variety of biphenyls and alkylarenes were obtained in good to excellent yields.

SUBSTITUTED HETEROCYCLIC COMPOUNDS

-

Page/Page column 29-30, (2009/01/23)

The present invention relates to novel heterocyclic compounds and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes. In particular embodiments, the structure of the compounds is given by Formula (I): wherein Q1, Q2, R2, R3, R4, R5, and R6 are as described herein. The invention also relates to methods for the preparation of the compounds, and to pharmaceutical compositions containing such compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1099640-02-4